Last reviewed · How we verify

Fluzone®: Influenza Virus Vaccine

Sanofi Pasteur, a Sanofi Company · FDA-approved active Biologic Quality 5/100

Fluzone®: Influenza Virus Vaccine is a Biologic drug developed by Sanofi Pasteur, a Sanofi Company. It is currently FDA-approved. Also known as: Fluzone®.

At a glance

Generic nameFluzone®: Influenza Virus Vaccine
Also known asFluzone®
SponsorSanofi Pasteur, a Sanofi Company
ModalityBiologic
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Fluzone®: Influenza Virus Vaccine

What is Fluzone®: Influenza Virus Vaccine?

Fluzone®: Influenza Virus Vaccine is a Biologic drug developed by Sanofi Pasteur, a Sanofi Company.

Who makes Fluzone®: Influenza Virus Vaccine?

Fluzone®: Influenza Virus Vaccine is developed and marketed by Sanofi Pasteur, a Sanofi Company (see full Sanofi Pasteur, a Sanofi Company pipeline at /company/sanofi).

Is Fluzone®: Influenza Virus Vaccine also known as anything else?

Fluzone®: Influenza Virus Vaccine is also known as Fluzone®.

What development phase is Fluzone®: Influenza Virus Vaccine in?

Fluzone®: Influenza Virus Vaccine is FDA-approved (marketed).

Related